Latest return on equity
Prelude Therapeutics Return on equity
Direct answer
Prelude Therapeutics's return on equity is -57.73%.
The verified market snapshot reports -57.73%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free Prelude Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -57.73%
Explore related company data
View Prelude Therapeutics's market capitalizationView Prelude Therapeutics's price-to-book ratioView Prelude Therapeutics's dividend yieldView Prelude Therapeutics's 52-week price rangeView Prelude Therapeutics's profit marginView Prelude Therapeutics's debt-to-equity ratioView all Prelude Therapeutics key metricsReturn to Prelude Therapeutics profile